Funding awarded Collaborative genomic alterations and transcriptional control in prostate cancer awarded by National Cancer Institute Key Personnel 2019 - 2024
education and training Ph.D., Tianjin Medical University (China) 2021 B.S., Yan'an University (China) 2016